Visionary Ventures: Funding, Team & Investors | Startup Intros

Loading organizations...

Visionary Ventures: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 1, 2025	Pelage Pharmaceuticals	$120.0M Series B	ARCH Venture Partners, Cathy Friedman	Main Street Advisors, YK Bioventures
Aug 1, 2025	Iantrek	$42.0M Series C	U.S. Venture Partners	aMoon Fund, Casey Tansey, Civilization Ventures, Radius Special Situations Fund, Sectoral Asset Management
Feb 27, 2024	Pelage Pharmaceuticals	$16.8M Series A	Cathy Friedman	Main Street Advisors, YK Bioventures
Nov 1, 2022	Re-Vana Therapeutics	$12.0M Vana Therapeutics - Series A	Robert Avery	ExSight Capital Management, ExSight Ventures, InFocus Capital Partners, QUBIS, Techstart Ventures
Aug 30, 2022	Iantrek	$23.0M Series B	Marc-Andre Marcotte, CFA, Farrell Tyson, Jeffry Weinhuff	—
Apr 1, 2022	Aurion Biotechnologies	$120.0M Venture Round	Deerfield Management	Alcon, Falcon Vision, Flying L Partners, Patrick Lally
Aug 10, 2021	Sydnexis	$45.0M Series B	Tyler Stowater, SC Master Fund, Jeffry Weinhuff	Gregory Grunberg, M.D., Medicxi, Zach Scheiner
Aug 12, 2020	TearClear	$22.0M Series B	—	Bluestem Capital, Falcon Vision, Flying L Partners
Jun 1, 2020	Re-Vana Therapeutics	$3.0M Vana Therapeutics - Seed	Firas Rahhal	ExSight Capital Management, Clarendon Fund Managers, Ron Weiss, QUBIS, Techstart Ventures, Garrett Hamontree
Jan 8, 2020	Tarsus Pharmaceuticals	$60.0M Series B	Chen Yu	Aperture Venture Partners, Flying L Partners, Frazier Healthcare Partners, Horowitz Group
Jun 1, 2018	Orasis Pharmaceuticals	$13.0M Series B	Visionary Ventures	Sequoia Capital Israel, Rafi Gidron